Skip to content

Medical emergency? What to do

HDL-Associated Protein Gene Linked to Heart Disease Risk

3-RXPublished March 19, 20083 min read

Key points

  • Hazen, M.D., Ph.D., of the Cleveland Clinic, presented the findings of the study at a JAMA media briefing at the National Press Club in Washington, D.C.
  • Hazen and colleagues conducted a study to examine the association between PON1 activity (such as anti-inflammatory and antioxidant activities) and if a PON1 gene variation (polymorphism) Q192R were associated with a higher rate of cardiovascular disease and major adverse cardiac events (heart attack, stroke or death).
  • “The current findings provide direct prospective evidence of an important mechanistic link between the PON1 gene and PON1 systemic activity measures with both multiple quantitative indices of oxidative stress and atherosclerotic heart disease development in humans.
  • Despite evidence that PON1 prevents atherosclerosis in animals, a cardio-protective role in humans has not been established.

The gene for the HDL-associated protein paraoxonase 1 (PON1) appears to be associated with coronary artery disease and with the risk of developing adverse cardiac events, and variations in both the PON1 gene and its related enzyme activity may increase the risk for cardiovascular disease events, according to a study in the March 19 issue of JAMA, a theme issue on Genetics and Genomics.

Stanley L. Hazen, M.D., Ph.D., of the Cleveland Clinic, presented the findings of the study at a JAMA media briefing at the National Press Club in Washington, D.C.

Despite evidence that PON1 prevents atherosclerosis in animals, a cardio-protective role in humans has not been established. Several studies have suggested that PON1 may have antioxidant and cardio-protective properties, according to background information in the article.

Dr. Hazen and colleagues conducted a study to examine the association between PON1 activity (such as anti-inflammatory and antioxidant activities) and if a PON1 gene variation (polymorphism) Q192R were associated with a higher rate of cardiovascular disease and major adverse cardiac events (heart attack, stroke or death). The study included 1,399 patients undergoing elective diagnostic coronary angiography between September 2002 and November 2003, and were followed-up until December 2006.

The researchers found that the incidence of major adverse cardiac events was significantly lower in participants in the highest PON1 activity quartile (7.3 percent for paraoxonase) compared with those in the lowest activity quartile (25.1 percent for paraoxonase).

The results also indicated that variations of the PON1 gene demonstrated significant dose-dependent associations with decreased levels of serum PON1 activity and increased levels of measures of oxidative stress (damage to cells and tissues from an imbalance between excess free radicals and not enough antioxidants), and that the PON1 Q192R polymorphism and serum PON1 activity were associated with both coronary artery disease and adverse cardiovascular events over the ensuing three year period after enrollment in the study.

“The current findings provide direct prospective evidence of an important mechanistic link between the PON1 gene and PON1 systemic activity measures with both multiple quantitative indices of oxidative stress and atherosclerotic heart disease development in humans. Paraoxonase 1 is [strongly] associated with HDL particles within the circulation and has been argued to promote some of the anti-inflammatory and antioxidant effects attributed to HDL. Thus, the present studies also provide further support for the concept that functional properties beyond the ability of HDL and its associated proteins to promote reverse cholesterol transport contribute to the overall ability of this lipoprotein to reduce or prevent development of atherosclerosis,” the authors conclude.
(JAMA. 2008;299[11]:1265-1276. Available pre-embargo to the media at www.jamamedia.org)

Source: American Medical Association (AMA)

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underGeneticsHeart

Keep reading

Heart

Comedian Gallagher still in medically induced coma

Doctors have decided to wait before bringing the comedian Gallagher out of the medically induced coma he was put in after his heart attack last week in Texas. Doctors had planned to wake the 65-year-old comedian on…

1 min read

Heart

10 Risk Factors for Heart Disease

Heart disease is the number one killer in the world. Several factors that increase the risk for heart disease have been identified by the American Heart Association. Scientific studies have shown significant risk…

5 min read

Heart

Hearts Actually Can Break

Dorothy Lee and her husband of 40 years were driving home from a Bible study group one wintry night when their car suddenly hit the curb. Mrs. Lee looked at her husband, who was driving, and saw his head bob a couple…

8 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.